CHAMP-Path Study Updates -- Nov. 2013
Outcomes Following Coronary Stenting: A National Study of Long Term, Real-World Outcomes of Bare-Metal and Drug-Eluting Stents Pamela S. Douglas, J. Matthew.
Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Access to HCV triple therapy with Telaprevir or Boceprevir in a real-life setting in HIV-HCV.
Members of the temperature module: T. Dziedzic (Poland), P. Michel (Switzerland), V. Papavasileiou (Greece), J. Petersson (Sweden), D. Staykov (Germany).
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial Sponsored by Bristol-Myers Squibb and Pfizer Samuel Z. Goldhaber, MD Brigham and Womens.
Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronisation Therapy: A Randomised Controlled Trial (TARGET study) Khan FZ 1,2, Virdee MS.
Huseyin Ergin and Eugene Syriani University of Alabama Software Modeling Lab Software Engineering Group Department of Computer Science College of Engineering.
AHA: RAFT Trial
Mary jane platt_conf_10
Management of non responders khi
Donovan value chain_conference_2012
Assay
